R1 RCM Named Top-Tier Software Vendor by APPS RUN THE WORLD in the APPS and CLOUD TOP 500 Market Report

R1 RCM Strengths, Domain Expertise, and Key Differentiators

R1 RCM excels in delivering technology-driven solutions that enhance both the patient experience and the financial performance of healthcare providers. One of its core strengths lies in its diverse product portfolio, offering comprehensive solutions tailored to the specific needs of its clientele. Furthermore, R1 RCM integrates advanced AI features into its offerings, enabling data-driven insights and optimizing operational efficiency for its customers. Through these strengths, R1 RCM remains at the forefront of innovation, driving sustainable improvements in healthcare delivery while prioritizing the satisfaction of patients, physicians, and staff alike.

R1 RCM Recent Developments

In 2024, R1 RCM, a leading revenue cycle management technology firm,has received an offer from private equity firm New Mountain Capital to buy out the roughly two-thirds of shares it doesn’t already own and take the company private.The firm and its affiliates currently control 32.4% of R1 RCM’s shares and are seeking to acquire the remainder for a proposed cash purchase price of $13.75 per share.

In August 2021, R1 RCM introduced R1 Entri, an intelligent patient engagement solution. Entri’s intuitive digital self-service capabilities empower patients to search, book, register and pay for care all in one experience, on any device. Entri was created to simplify the healthcare process and eliminate the pervasive friction that plagues today’s patient journeys and provider interactions. Powered by R1 proprietary technologies, automation and deep domain expertise, Entri enables the total transformation of the revenue cycle process, helping patient and provider interactions start strong and consistently develop into lasting relationships.

R1 RCM Mergers and Acquisitions (M&A) Activities

In 2023, R1 RCM a prominent player in healthcare technology solutions aimed at enhancing patient experience and financial performance for providers, has recently finalized its acquisition of Acclara, one of the nation's leading health systems.This acquisition underscores R1's commitment to innovation and technology, positioning it as a preferred partner in revenue cycle management.

In January 2022, R1 RCM has entered into a definitive agreement to acquire Cloudmed, provider of Revenue Intelligence solutions for healthcare providers, in an all-stock transaction. Cloudmed’s revenue intelligence platform combines cloud-based data architecture and deep domain expertise with intelligent automation to analyze large volumes of medical records, payment data, and complex medical insurance models to identify opportunities to deliver additional revenue to customers.

In May 2021, R1 RCM acquired VisitPay, the digital payment solution provider for approximately $300 million in cash. VisitPay’s cloud-based platform is used by the nation’s largest and most innovative health systems to transform the payment experience and drive both improved patient satisfaction and higher collection yield. VisitPay’s enterprise platform gives healthcare providers and patients the tools needed to make the healthcare financial experience simple and efficient.

In April 2020, R1 RCM has completed the acquisition of SCI Solutions, Inc. (SCI). The combination of R1 and SCI is expected to deliver enhanced value for healthcare providers by enabling them to expand digital front door strategies for their patients, improve operating efficiency, and increase capacity utilization, among other benefits.

R1 RCM Customers in ARTW Customer Database

Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying R1 RCM applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of R1 RCM and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified R1 RCM, R1 Entri,R1 Denials Recovery,R1 Entri Pay customers.

R1 RCM Key Enterprise and Cloud Applications

R1 RCM, R1 Entri,R1 Denials Recovery,R1 Entri Pay

R1 RCM Revenues, $M:

R1 RCM Revenue Breakdown By Type, $M:

R1 RCM Enterprise Applications Revenues By Functional Markets, $M:

R1 RCM Enterprise Applications Revenues By Verticals, $M:

R1 RCM Revenues By Region, $M

R1 RCM Direct vs Indirect sales

R1 RCM Customers - Breakdown by Geo, Size, Vertical and Product

List of Verified R1 RCM Customers

No. of R1 RCM Customers: 900

No. of R1 RCM Enterprise Applications Customers: 900

No. of R1 RCM Cloud Customers: x

No. of R1 RCM Cloud Subscribers: x

R1 RCM customers typically are healthcare providers, including health systems, hospitals, and physician groups. R1 RCM seek to develop strategic, long-termrelationships with customers and focus on providers understand the value of the operating model and have demonstrated success in both the provision of healthcare services and the ability to achieve financial and operational results.

R1 RCM Market Opportunities, M&A and Geo Expansions

Amidst the offer from New Mountain Capital to acquire the majority of shares in R1 RCM, the revenue cycle management giant stands at the brink of significant opportunities for growth and innovation. With market opportunities spanning both horizontal and vertical levels, R1 RCM is poised to leverage its expertise in revenue cycle management across diverse sectors.R1 RCM navigates through this pivotal juncture, these opportunities offer the potential for unparalleled growth and innovation, propelling the company towards greater success and market leadership.

R1 RCM Risks and Challenges

The recent appointments of Jennifer Williams as Chief Financial Officer and Kyle Hicok as Chief Commercial Officer come at a critical juncture for R1 RCM as the company navigates through a landscape fraught with internal and external risks alongside go-to-market challenges.Williams and Hicok's arrival signals a strategic move by R1 RCM to bolster its leadership team, ensuring the company is well-equipped to address and mitigate these multifaceted risks while effectively capitalizing on market opportunities.

COVID-19 continues to be characterized as a pandemic by the World Health Organization. Despite the availability of vaccines, the emergence of new virus variances and surges in cases and hospitalizations have required international,federal, state and local governments to continuously update certain restrictions on businesses and travel, and future changes or elimination of such restrictions cannotbe predicted with certainty. These measures continue to impact R1 RCM workforce and operations and the operations of their customers. These impacts continue to include the need for personal protective equipment and other protective measures for front-line employees and work-from-home arrangements. Additionally, R1 RCM have seen declines in patient volumes, which reflects the response of many patients and providers to governmental restrictions, economic impacts, and concerns regarding thespread of the virus in which elective procedures and physician visits have been delayed or cancelled.

R1 RCM Ecosystem, Partners, Resellers and SI

R1 RCM a provider of technology-driven solutions that transform the patient experience and financial performance for healthcare providers, and ScionHealth have entered into an agreement that will make R1 the exclusive provider of revenue cycle management (RCM) services for ScionHealth’s 61 long-term acute care hospitals (LTACHs). Launched in December 2021, ScionHealth is a new health system comprised of 61 LTACHs previously owned by Kindred Healthcare and 18 short-term acute care community hospitals previously owned by LifePoint Health.

R1 RCM Cloud Infrastructure Insights

Subscribe to read more about:

• R1 RCM Public Cloud and Infrastructure (IaaS)
• R1 RCM Platform (PaaS)
• R1 RCM Application Delivery
• R1 RCM Private Cloud and Data Centers

Research Methodology

Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.

Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).

For additional information on our methodologies, here's the link: